Big Four firm will also ‘sunset’ its diversity goals as part of shift after Trump’s electionRead More
You might also be interested in reading IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study.